C4 Therapeutics Inc logo

C4 Therapeutics Inc

NAS:CCCC (USA)   Ordinary Shares
$ 8.99 +0.19 (+2.16%) 10:08 PM EST
At Loss
P/B:
2.05
Market Cap:
$ 616.38M
Enterprise V:
$ 471.99M
Volume:
4.28M
Avg Vol (2M):
5.71M
Volume:
4.28M
At Loss
Avg Vol (2M):
5.71M

Business Description

C4 Therapeutics Inc logo
C4 Therapeutics Inc
NAICS : 541714 SIC : 2834
ISIN : US12529R1077

Share Class Description:

CCCC: Ordinary Shares
Description
C4 Therapeutics Inc is a biopharmaceutical company advancing targeted protein degradation science to develop a new generation of small-molecule medicines to transform how the disease is treated. Its TORPEDO platform enables the discovery of a new class of targeted investigational small-molecule medicines called protein degraders.
Name Current Vs Industry Vs History
Cash-To-Debt 3
Equity-to-Asset 0.65
Debt-to-Equity 0.33
Debt-to-EBITDA -0.56
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.54
Distress
Grey
Safe
Beneish M-Score -3.85
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year Revenue Growth Rate -65.6
3-Year EBITDA Growth Rate 52.1
3-Year EPS without NRI Growth Rate 56.1
Name Current Vs Industry Vs History
5-Day RSI 79.46
9-Day RSI 75.01
14-Day RSI 71.09
6-1 Month Momentum % 70.39
12-1 Month Momentum % -6.31

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 7.39
Quick Ratio 7.39
Cash Ratio 7.15
Days Sales Outstanding 18

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -229.2
Shareholder Yield % -0.95

Financials (Next Earnings Date:2024-05-03 Est.)

CCCC's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:CCCC

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

C4 Therapeutics Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 20.349
EPS (TTM) ($) -2.75
Beta 3
Volatility % 269.46
14-Day RSI 71.09
14-Day ATR ($) 0.709237
20-Day SMA ($) 6.74725
12-1 Month Momentum % -6.31
52-Week Range ($) 1.06 - 9.66
Shares Outstanding (Mil) 68.6

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

C4 Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

C4 Therapeutics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

C4 Therapeutics Inc Frequently Asked Questions

What is C4 Therapeutics Inc(CCCC)'s stock price today?
The current price of CCCC is $8.99. The 52 week high of CCCC is $9.66 and 52 week low is $1.06.
When is next earnings date of C4 Therapeutics Inc(CCCC)?
The next earnings date of C4 Therapeutics Inc(CCCC) is 2024-05-03 Est..
Does C4 Therapeutics Inc(CCCC) pay dividends? If so, how much?
C4 Therapeutics Inc(CCCC) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1